Beverly – April 3, 2020 – Venture-backed medical technology development company, LeviSense Medical, Inc., joined the 600+ wound care professionals who attended the Annual Conference of the National Pressure Injury Advisory Panel (NPIAP) in Houston, TX, March 27-28, 2020.
The attendees were presented the groundbreaking scientific research that lead to significant changes in the 2019 Guideline for Clinical Practice, updating the 2014 guidelines. The guideline is the 400-plus-page reference used by wound care professionals to guide the treatment and prevention of pressure injuries. The scientists whose work created the foundation of the new guidelines presented their work to a fascinated audience.
“I have never attended this conference before and I was impressed how the science was translated to clinical practice for the wound care specialists. I will have the key members of my staff attend in the future,” said Dr. Richard Viglione, LeviSense’s clinical advisor.
“The NPIAP National Conference is a must for anyone serious about leading positive change in wound care products and practices,” Said Dave Bertoni, President of LeviSense.
About LeviSense Medical, Inc.:
LeviSense Medical, Inc. is a Boston area medical technology firm engaged in developing a therapeutic bed system that will advance the prevention and treatment of pressure induced wounds and ulcers in a variety of patient populations and disease states.
For more information about LeviSense, visit the company’s Web site at www.LeviSenseMedical.com.